Work

A single-arm phase II trial of gemcitabine, oxaliplatin, and panitumumab in KRAS wild-type advanced biliary tract cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.255

Authors: Marcus Smith Noel, Jill N. Allen, Thomas Adam Abrams, Matthew Yurgelun, Jason Edward Faris, Lipika Goyal, Jeffrey W. Clark, Lawrence Scott Blaszkowsky, Janet E. Murphy, Hui Zheng, Alok A. Khorana, Gregory Clayton Connolly, Ollivier Hyrien, Kimmie Ng, Darrell R. Borger, Anthony John Iafrate, Aram F. Hezel, Andrew X. Zhu

Institutions: University of Rochester, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Cleveland Clinic, University of Rochester Medicine

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590006655

Cites:

Cited by:

Related to: 10